• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Successful treatment of eruptive xanthomatosis with the antilipemic agents acipimox].

作者信息

Zahorcsek Z, Schneider I, Hortobágyi J

机构信息

Dermatologische Klinik, Medizinischen Universität, Pécs.

出版信息

Hautarzt. 1995 Feb;46(2):124-6. doi: 10.1007/s001050050222.

DOI:10.1007/s001050050222
PMID:7706071
Abstract

A 51-year-old male patient with histologically confirmed eruptive xanthomatosis is presented. Routine and special laboratory examinations showed complex disturbances of carbohydrate and lipid metabolism, the latter taking the form of classic hyperlipoproteinaemia type IV. Combined oral antilipaemic drugs including acipimox (methylpyrazine carboxylic acid analogue of nicotinic acid) and a low-fat diet resulted in regression of the skin symptoms and normalization of the serum lipid levels.

摘要

相似文献

1
[Successful treatment of eruptive xanthomatosis with the antilipemic agents acipimox].
Hautarzt. 1995 Feb;46(2):124-6. doi: 10.1007/s001050050222.
2
A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia.
Atherosclerosis. 1985 Apr;55(1):51-62. doi: 10.1016/0021-9150(85)90165-0.
3
A comparison between nicotinic acid and acipimox in hypertriglyceridaemia--effects on serum lipids, lipoproteins, glucose tolerance and tolerability.烟酸与阿西莫司治疗高甘油三酯血症的比较——对血脂、脂蛋白、葡萄糖耐量及耐受性的影响
J Intern Med. 1991 Nov;230(5):415-21. doi: 10.1111/j.1365-2796.1991.tb00466.x.
4
Results of a phase IV study carried out with acipimox in type II diabetic patients with concomitant hyperlipoproteinaemia.在伴有高脂蛋白血症的II型糖尿病患者中使用阿西莫司进行的IV期研究结果。
J Int Med Res. 1989 Jul-Aug;17(4):373-80. doi: 10.1177/030006058901700411.
5
Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, a new inhibitor of lipolysis.
Atherosclerosis. 1981 Feb-Mar;38(3-4):267-71. doi: 10.1016/0021-9150(81)90042-3.
6
[Eruptive xanthomas].[发疹性黄瘤]
Hautarzt. 2004 Oct;55(10):978-80. doi: 10.1007/s00105-004-0810-8.
7
[Effect of acipimox on diabetes mellitus-associated hyperlipoproteinemia].阿西莫司对糖尿病相关高脂蛋白血症的作用
Orv Hetil. 1993 Jan 17;134(3):121-4.
8
Eruptive xanthomas. Papules may indicate underlying lipid disorder.发疹性黄瘤。丘疹可能提示潜在的脂质紊乱。
Postgrad Med. 2005 Aug;118(2):11-2. doi: 10.3810/pgm.2005.08.1698.
9
Cost-effectiveness study of a lipid-lowering therapy in hyperlipoproteinaemia type IIb and type IV (Frederickson).IIb型和IV型(弗雷德里克森分类法)高脂蛋白血症降脂治疗的成本效益研究
Pharmacoeconomics. 1993 Feb;3(2):131-9. doi: 10.2165/00019053-199303020-00006.
10
[Personal experience with the hypolipidemic agent Olbetam-Acipimox in hyperlipoproteinemia associated with type II diabetes].[降血脂药物奥贝他(阿昔莫司)治疗Ⅱ型糖尿病合并高脂蛋白血症的个人经验]
Cas Lek Cesk. 1991 Nov 29;130(22-23):661-3.